LBF20406AM20: Difference between revisions

← Older edit

Latest revision as of 13:44, 21 October 2010

LipidBank Top
(トップ)

Fatty acid
(脂肪酸)

Glycerolipid
(グリセロ脂質)

Sphingolipid
(スフィンゴ脂質)

Journals
(雑誌一覧)

How to edit
(ページの書き方)

Upper classes: LB LBF

N'-Arachidonoyl-N"-diethylethylenediamine

Structural Information
	N'- (cis-5,cis-8,cis-11,cis-14) -Eicosatetraenoyl-N"-diethylethylenediamine
	N'-Arachidonoyl-N"-diethylethylenediamine N'- (5Z,8Z,11Z,14Z) -Eicosatetraenoyl-N"-diethylethylenediamine

Formula	C26H44N2O
Exact Mass	400.34536404
Average Mass	400.64043999999996
SMILES	`C(CCC)CC=CCC=CCC=CCC=CCCCC(=O)NC=CN(CC)CC`
Physicochemical Information
	colorless oil Sheskin_T et al.






	This compound was synthesized from arachidonoylchloride and N,N-diethylenediamine. Yield 70 %. Sheskin_T et al.

	Binding to the brain cannabinoid receptor (CBl), Ki(nM)>1000 Sheskin_T et al.


Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra	¹H NMR (CDCl3) δ 6.10 (br s lH), 5.26-5.42 (m, 8H), 3.22-3.30 (m, 2H), 2.76-2.90 (m, 6H), 2.50-2.62 (m, 6H), 1.66-1.80 (m, 2H), 1.20-1.40 (m, 6H), 1.02 (t, J=7.1Hz, 6H), 0.89 (t, J=6.5Hz, 3H). Sheskin_Tet al.
Other Spectra
Chromatograms

Reported Metabolites, References

Biospecies	ID	Compound Name	Reference	Comment
n.a.	LBF20406AM20	See above.	Sheskin_T et al. 1997

@@ Line 6: / Line 6: @@
 |LipidBank=XPR7036
 |LipidMaps=LMFA08020022
-|SysName=N'-arachidonoyl-N"-diethylethylenediamine
+|SysName=N'- (cis-5,cis-8,cis-11,cis-14) -Eicosatetraenoyl-N"-diethylethylenediamine
-|Common Name=&&N'-arachidonoyl-N"-diethylethylenediamine&&
+|Common Name=&&N'-Arachidonoyl-N"-diethylethylenediamine&&N'- (5Z,8Z,11Z,14Z) -Eicosatetraenoyl-N"-diethylethylenediamine&&
 |Melting Point=colorless oil [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
-|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H NMR (CDCl3) <FONT FACE="Symbol">d</FONT>6.10 (br s lH), 5.26-5.42 (m, 8H), 3.22-3.30 (m, 2H), 2.76-2.90 (m, 6H), 2.50-2.62 (m, 6H), 1.66-1.80 (m, 2H), 1.20-1.40 (m, 6H), 1.02 (t, J=7.1Hz, 6H), 0.89 (t, J=6.5Hz, 3H). [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
+|NMR Spectra=^1 H NMR (CDCl3)  delta 6.10 (br s lH), 5.26-5.42 (m, 8H), 3.22-3.30 (m, 2H), 2.76-2.90 (m, 6H), 2.50-2.62 (m, 6H), 1.66-1.80 (m, 2H), 1.20-1.40 (m, 6H), 1.02 (t, J=7.1Hz, 6H), 0.89 (t, J=6.5Hz, 3H). [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
+|Source=
+|Chemical Synthesis=This compound was synthesized from arachidonoylchloride and N,N-diethylenediamine. Yield 70 %. [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
+|Metabolism=
+|Biological Activity=Binding to the brain cannabinoid receptor (CBl), Ki(nM)>1000 [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
 }}
 {{Lipid/Footer}}

IDs and Links
LipidBank	XPR7036
LipidMaps	LMFA08020022
CAS
KEGG	{{{KEGG}}}
KNApSAcK	{{{KNApSAcK}}}

mol	LBF20406AM20

LBF20406AM20: Difference between revisions

Latest revision as of 13:44, 21 October 2010

Navigation

Tools